Redwood Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.09M | Buy |
+4,348
| New | +$935K | 0.11% | 193 |
|
|
2025
Q4 | – | Sell |
-1,202
| Closed | -$278K | – | 296 |
|
|
2025
Q3 | $278K | Sell |
1,202
-3,489
| -74% | -$710K | 0.03% | 265 |
|
|
2025
Q2 | $871K | Sell |
4,691
-1,031
| -18% | -$192K | 0.09% | 229 |
|
|
2025
Q1 | $1.2M | Sell |
5,722
-7,911
| -58% | -$1.54M | 0.13% | 217 |
|
|
2024
Q4 | $2.42M | Buy |
13,633
+11,685
| +600% | +$2.15M | 0.24% | 64 |
|
|
2024
Q3 | $385K | Sell |
1,948
-83
| -4% | -$15.5K | 0.03% | 290 |
|
|
2024
Q2 | $367K | Buy |
2,031
+353
| +21% | +$58.5K | 0.03% | 299 |
|
|
2024
Q1 | $305K | Sell |
1,678
-15,651
| -90% | -$2.7M | 0.03% | 301 |
|
|
2023
Q4 | $2.69M | Sell |
17,329
-4,121
| -19% | -$601K | 0.25% | 83 |
|
|
2023
Q3 | $3.2M | Buy |
21,450
+8,434
| +65% | +$1.24M | 0.28% | 76 |
|
|
2023
Q2 | $1.75M | Sell |
13,016
-6,130
| -32% | -$899K | 0.18% | 130 |
|
|
2023
Q1 | $3.05M | Buy |
19,146
+5,366
| +39% | +$820K | 0.33% | 84 |
|
|
2022
Q4 | $2.23M | Buy |
13,780
+9,116
| +195% | +$1.4M | 0.3% | 84 |
|
|
2022
Q3 | $626K | Buy |
4,664
+3,017
| +183% | +$433K | 0.13% | 157 |
|
|
2022
Q2 | $252K | Buy |
1,647
+254
| +18% | +$38.8K | 0.04% | 208 |
|
|
2022
Q1 | $226K | Sell |
1,393
-13,878
| -91% | -$2.02M | 0.03% | 254 |
|
|
2021
Q4 | $2.07M | Buy |
15,271
+4,382
| +40% | +$518K | 0.27% | 86 |
|
|
2021
Q3 | $1.18M | Sell |
10,889
-256
| -2% | -$29.3K | 0.17% | 160 |
|
|
2021
Q2 | $1.25M | Buy |
11,145
+2,050
| +23% | +$231K | 0.21% | 137 |
|
|
2021
Q1 | $984K | Sell |
9,095
-487
| -5% | -$52.1K | 0.19% | 142 |
|
|
2020
Q4 | $1.03M | Buy |
9,582
+1,307
| +16% | +$126K | 0.17% | 104 |
|
|
2020
Q3 | $725K | Sell |
8,275
-136
| -2% | -$12.8K | 0.18% | 158 |
|
|
2020
Q2 | $826K | Buy |
+8,411
| New | +$741K | 0.24% | 88 |
|
|
2020
Q1 | – | Sell |
-4,514
| Closed | -$400K | – | 152 |
|
|
2019
Q4 | $400K | Sell |
4,514
-47,313
| -91% | -$3.93M | 0.1% | 211 |
|
|
2019
Q3 | $3.92M | Buy |
51,827
+2,791
| +6% | +$191K | 1.06% | 23 |
|
|
2019
Q2 | $3.57M | Buy |
49,036
+11,665
| +31% | +$917K | 1% | 27 |
|
|
2019
Q1 | $3.01M | Buy |
+37,371
| New | +$3.06M | 1.28% | 14 |
|
|
2018
Q4 | – | Sell |
-2,936
| Closed | -$278K | – | 56 |
|
|
2018
Q3 | $278K | Buy |
+2,936
| New | +$278K | 0.1% | 110 |
|
Other funds holding ABBV
Redwood Investment Management's ABBV Position: Q2 2026 in Review
Redwood Investment Management opened a new position in AbbVie (ABBV) in Q2 2026: 4,348 shares worth $1.09M. The stake represents 0.11% of the portfolio and ranks #193 among its holdings. This is a return to the name: Redwood Investment Management previously reported a position in ABBV as recently as Q3 2025.
Redwood Investment Management first reported a position in ABBV in Q3 2018 and has held it in 28 quarters since. The position peaked at $3.92M in Q3 2019. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Redwood Investment Management held 4,348 shares of AbbVie worth $1.09M as of Q2 2026.
- AbbVie was a new Redwood Investment Management position in Q2 2026.
- AbbVie made up 0.11% of Redwood Investment Management's portfolio in Q2 2026, its #193 holding.
- Redwood Investment Management first reported a position in AbbVie in Q3 2018 and has held it in 28 quarters since.
- Redwood Investment Management's AbbVie position peaked at $3.92M in Q3 2019.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Redwood Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.